MDAI
Spectral AI, Inc.
NASDAQ
Listed Apr 6, 2021
Healthcare
· Medical - Devices
· US
·
spectral-ai.com
52w Low $1.13
53.8% of range
52w High $3.21
50d MA $1.65
200d MA $1.84
P/E (TTM)
-7.4x
EV/EBITDA
-4.1x
P/B
—
Debt/Equity
-1.8x
ROE
132.2%
P/FCF
-3.8x
RSI (14)
—
ATR (14)
—
Beta
0.91
50d MA
$1.65
200d MA
$1.84
Avg Volume
684.0K
About
Recent Earnings
Recent Analyst Ratings
Insider Trades
Recent Filings
Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
2515 McKinney Avenue · Dallas, TX 75201 · US
Date
Time
Est
Rptd
Surp
Base
Gap%
D1%
D2%
D3%
D4%
D5%
Guide ▲★
Mar 24, 2026
AMC
-0.12
-0.11
+8.3%
1.65
-3.0%
-6.7%
-1.3%
-2.0%
-2.0%
+0.7%
—
Nov 11, 2025
AMC
-0.09
-0.13
-52.9%
1.72
-4.1%
-7.0%
+3.1%
-7.9%
-5.3%
-0.7%
—
Aug 12, 2025
AMC
-0.07
-0.10
-42.9%
2.23
-7.2%
-4.9%
-0.9%
+0.5%
+0.5%
-0.5%
—
May 14, 2025
AMC
-0.10
0.11
+210.0%
1.30
+3.1%
+3.8%
+2.2%
-2.2%
+0.7%
+1.5%
—
Mar 27, 2025
AMC
-0.13
-0.06
+53.8%
1.28
-2.3%
-11.7%
+1.8%
+4.3%
+7.5%
-4.7%
—
Nov 6, 2024
AMC
-0.14
-0.02
+85.7%
1.51
-0.7%
-11.3%
+0.7%
+2.2%
-2.2%
+3.0%
—
Aug 12, 2024
AMC
-0.14
-0.16
-14.3%
1.66
+3.6%
-9.6%
+5.3%
+4.4%
-6.1%
+1.3%
—
May 7, 2024
AMC
-0.26
-0.19
+26.9%
1.72
-0.6%
+0.6%
-2.9%
+1.8%
-2.9%
+1.8%
—
Mar 27, 2024
AMC
-0.22
-0.22
+0.0%
2.12
+4.7%
+0.5%
+9.4%
+5.6%
+0.4%
-2.8%
—
Nov 13, 2023
AMC
—
-0.30
—
2.81
-10.3%
-2.1%
-1.5%
-0.4%
-3.0%
-0.4%
—
Jun 30, 2023
AMC
—
-0.17
—
10.60
-1.1%
-1.1%
+1.0%
+0.0%
-0.6%
+0.6%
—
Mar 31, 2023
AMC
—
-0.20
—
9.96
+0.1%
+0.8%
+0.0%
-0.8%
+0.0%
+0.0%
—
Show 2 more
Date
Firm
Action
Grade
Target
Base
Open
Gap%
D1%
D2%
D3%
D4%
D5%
Mar 25
BTIG
Maintains
Buy → Buy
—
$1.65
$1.60
-3.0%
-6.7%
-1.3%
-2.0%
-2.0%
+0.7%
Feb 10
BTIG
Maintains
Buy → Buy
—
$1.55
$1.58
+1.9%
+0.6%
-1.3%
-1.9%
+2.6%
-1.9%
Nov 12
BTIG
Maintains
Buy → Buy
—
$1.72
$1.65
-4.1%
-7.0%
+3.1%
-7.9%
-5.3%
-0.7%
Apr 2
HC Wainwright & Co.
Maintains
Buy → Buy
—
$1.20
$1.22
+1.7%
+7.5%
-4.7%
-1.6%
-2.5%
+0.8%
Mar 18
HC Wainwright & Co.
Maintains
Buy → Buy
—
$1.76
$1.74
-1.1%
-4.5%
-3.0%
+1.8%
+2.4%
-12.4%
Aug 13
HC Wainwright & Co.
Maintains
Buy → Buy
—
$1.66
$1.72
+3.6%
-9.6%
+5.3%
+4.4%
-6.1%
+1.3%
No insider trades available.
8-K · 5.02
!!! Very High
Spectral AI, Inc. -- 8-K 5.02: Executive Change
Spectral AI (MDAI) formalized Capone's CEO appointment with a $500,000 annual base salary, confirming leadership continuity after his February 2026 announcement.
Apr 22
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
MDAI appointed a financial executive with complex accounting expertise, suggesting potential operational restructuring or improved financial reporting rigor that could enhance investor confidence and reduce restatement risks.
Apr 8
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Spectral AI generated $19.7M in 2025 revenue with $15.4M cash on hand and provided 2026 guidance, signaling operational progress and runway extension for investors evaluating the AI healthcare company's path to profitability.
Mar 25
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Spectral AI secured $31.7 million in government funding from BARDA to advance its DeepView diagnostic system, significantly de-risking product development and potentially accelerating commercialization and revenue growth.
Mar 20
8-K · 5.02
!!! Very High
Spectral AI, Inc. -- 8-K 5.02: Executive Change
Spectral AI (MDAI) has appointed Vincent S. Capone as Chief Executive Officer, signaling a leadership transition that investors should monitor for strategic direction changes and execution capabilities.
Feb 10
8-K · 5.02
!!! Very High
Spectral AI, Inc. -- 8-K 5.02: Executive Change
Spectral AI's Chief Commercial Officer Jeremiah Sparks resigned to pursue other opportunities, with no operational disagreements cited, potentially affecting the company's commercial strategy execution.
Feb 3
Data updated apr 26, 2026 11:37am
· Source: massive.com
